Target CMS 2025 Interview Expected Q
Why examiner asks:
Tests diagnostic reasoning and differential-building approach.
How to answer:
State classical definition and broad causes.
Model Answer:
PUO = fever ≥ 38.3°C (101°F) on ≥ 2 occasions lasting > 3 weeks, and diagnosis not made after 1 week of inpatient evaluation.
Causes (Major Groups):
1️⃣ Infectious: TB, abscess, endocarditis.
2️⃣ Malignancy: Lymphoma, leukemia.
3️⃣ Autoimmune: SLE, vasculitis, adult-onset Still’s disease.
4️⃣ Miscellaneous: Drug fever, factitious.
Tip (Clue): “Rule out infection → inflammation → infiltration.”
Approach: Reassess history/exam → basic labs (CBC, ESR/CRP, blood cultures ×3, LFT/RFT, urinalysis, chest X-ray) → targeted tests guided by clues (CT chest/abdomen, TB workup, serology, autoimmune markers, PET-CT if available) → biopsy of accessible lesion (lymph node, liver, bone marrow) if persists.
• Key: Systematic stepwise testing; avoid blind broad antibiotics.
Why examiner asks:
Tests rational, supportive management and recognition of warning signs.
How to answer:
Supportive care + fluid management + monitoring.
Diagnosis: Suspected with high fever, severe myalgia, retro-orbital pain, rash, leucopenia/thrombocytopenia.
Confirm: NS1 antigen (early), IgM serology (from day 4–5), PCR (research/early).
Model Answer: supportive care is very important.
- No specific antiviral.
- Fluids: Oral rehydration or IV crystalloids (as per WHO 2024).
- Avoid NSAIDs & steroids. Use Paracetamol only.
- Monitor: Platelets, Hct, urine output.
- Transfuse platelets only if < 10,000/mm³ or bleeding.
- Warning signs: Monitor for warning signs (persistent vomiting, abdominal pain, bleeding, rising hematocrit with falling platelets).→ admit.
Tip (Clue): “Dengue treatment = fluids, not platelets.” • Key: Fluid management and early detection of plasma leakage.
How to answer:
Identify species → classify → treat per NVBDCP.
Model Answer:
1️⃣ Diagnosis: Peripheral smear / Rapid antigen test (HRP2, pLDH).
2️⃣ Treatment:
- Uncomplicated P. vivax: Chloroquine (25 mg/kg over 3 days) + Primaquine 0.25 mg/kg daily × 14 days.
- Uncomplicated P. falciparum: ACT (Artemether–Lumefantrine 3 days) + Primaquine single dose 0.75 mg/kg (gametocidal).
- Severe malaria: IV Artesunate 2.4 mg/kg at 0, 12, 24 h → daily + supportive therapy, then ACT 3 days.
3️⃣ Supportive: Fluids, manage hypoglycemia, treat anemia.
Tip (Clue): “ACT for falciparum; Chloroquine for vivax.”
How to Answer:
Emphasize early stabilization, pain control, antivenom use, and management of autonomic storm (hypertension or pulmonary edema).
Model Answer:
1️⃣ First Aid at Scene:
- Reassure the patient (panic increases autonomic symptoms).
- Immobilize limb and apply ice pack (reduces pain and venom spread).
- Avoid tourniquet, incision, or suction.
2️⃣ Emergency Department Management:
Step | Management |
A – Airway/Breathing/Circulation | Monitor SpO₂, BP, HR. Start O₂ if distress or pulmonary edema. |
Analgesia | Lignocaine infiltration at sting site (preferred) or paracetamol. Avoid opioids. |
Antivenom | Scorpion Antivenom (SAV) 30–50 mL IV over 30 min (if systemic symptoms — sweating, salivation, hypertension, pulmonary edema). |
Autonomic Control | – Prazosin (alpha-blocker) is life-saving. 👉 Dose: 30 µg/kg orally every 3 h till improvement. – Avoid beta-blockers (can worsen hypertension). |
Pulmonary Edema / Shock | – IV fluids cautiously. – Dopamine/dobutamine if hypotensive. – Furosemide + oxygen if pulmonary edema. |
Observation | Monitor for 24 h (arrhythmia, pulmonary edema, shock). |
💡 Tip (Clue):
“Prazosin saves lives — give early and repeat if symptoms persist.”
📘 Reference:
Harrison 22/e, Ch. 410; API Textbook of Medicine 12/e, Vol 2; ICMR Guidelines on Scorpion Sting Management, 2023.
How to Answer:
Start with the main pathophysiologic difference → then compare features systematically under headings (urine, protein loss, edema, BP, cause).
Model Answer (Table Format)
Feature | Nephritic Syndrome | Nephrotic Syndrome |
Basic Pathology | Glomerular inflammation → ↓ GFR | Glomerular permeability defect → massive protein loss |
Proteinuria | < 3.5 g/day | > 3.5 g/day |
Hematuria | Present, often microscopic or RBC casts | Absent or minimal |
Edema | Mild to moderate (periorbital) | Severe, generalized (anasarca) |
BP | Elevated due to salt & water retention | Usually normal or slightly raised |
Serum Albumin | Mildly decreased | Markedly decreased (<3 g/dL) |
Urine Appearance | Cola-colored / smoky | Frothy urine |
Major Causes | Post-streptococcal GN, RPGN, SLE nephritis | Minimal change disease, FSGS, Membranous GN, Amyloidosis |
Complications | Acute renal failure, hypertension | Thrombosis, infection (due to protein loss) |
💡 Tip (Clue):
“Nephritic = inflammation & RBC; Nephrotic = permeability & protein.”
📘 Reference:
Harrison 22/e, Ch. 142; Brenner & Rector’s Nephrology 11/e
Model Answer (Structured & Impressive)
“Sir, during my emergency duties, I have managed multiple acute cases. I would like to briefly describe five of them that reflect both my clinical and team-handling skills:”
1️⃣ Myocardial Infarction (MI)
- Presentation: 55-year-old male with retrosternal chest pain and sweating.
- Action Taken: ABC stabilization, ECG done (ST elevation in II, III, aVF). Given aspirin, clopidogrel, statin, nitrate, started O₂ and IV access, arranged urgent cardiology referral.
- Learning: Importance of early ECG and teamwork for rapid thrombolysis.
2️⃣ Diabetic Ketoacidosis (DKA)
- Presentation: 30-year-old female with vomiting, dehydration, Kussmaul breathing.
- Action Taken: ABC stabilization, bedside sugar >400 mg/dL, started IV fluids → insulin infusion → potassium correction, monitored vitals and urine output.
- Learning: Fluids first, insulin second — and never forget potassium.
3️⃣ Road Traffic Accident (Polytrauma)
- Presentation: Unconscious male, bleeding from scalp, open tibial fracture.
- Action Taken: Followed ABCDE trauma protocol, controlled bleeding, immobilized limb, ensured airway with jaw thrust, stabilized vitals, arranged urgent CT and ortho + neuro consult.
- Learning: Importance of team coordination and prioritizing airway in polytrauma.
4️⃣ Acute Severe Asthma Attack
- Presentation: 25-year-old female with breathlessness, accessory muscle use, SpO₂ 84%.
- Action Taken: O₂, nebulized salbutamol + ipratropium, IV hydrocortisone, ABG done, improved after 30 mins.
- Learning: Timely bronchodilator + steroids save lives.
5️⃣ Organophosphate Poisoning
- Presentation: 40-year-old farmer with frothing, pinpoint pupils, bradycardia.
- Action Taken: Airway secured, atropine + pralidoxime, gastric lavage, monitored vitals.
- Learning: Early atropine and airway management are lifesaving.
💡 Tip (Clue):
“Always describe real cases in ABCDE sequence — it shows calmness and systematic thinking.”
📘 Reference:
ATLS 10/e; Harrison 22/e Ch. 1 (Emergency Medicine).
🔹 1️⃣ Life-Threatening Causes (must rule out first)
👉 Cardiac:
- Myocardial infarction / Unstable angina – retrosternal, radiating to arm/jaw, with sweating
- Aortic dissection – tearing pain radiating to back, pulse inequality, widened mediastinum
👉 Respiratory:
- Pulmonary embolism (PE) – pleuritic pain, dyspnea, tachycardia, risk factors for DVT
- Tension pneumothorax – sudden dyspnea, unilateral absent breath sounds, hypotension
👉 Gastro-esophageal rupture (Boerhaave’s) – post-vomiting, severe retrosternal pain, subcutaneous emphysema
🔹 2️⃣ Cardiac / Pericardial Causes
- Pericarditis – sharp, pleuritic, relieved by sitting forward
- Myocarditis – chest discomfort with fever/myalgia
🔹 3️⃣ Pulmonary Causes
- Pneumonia / pleurisy – fever, localized pain, crackles
- Bronchitis – dull retrosternal burning
🔹 4️⃣ Gastro-esophageal & Musculoskeletal Causes
- GERD / Esophageal spasm – retrosternal burning, post-meal
- Costochondritis / muscle strain – localized, reproducible on palpation
Approach (ABCDE + ECG-based):
A → Airway & breathing assessment
B → ECG + Troponin to rule out MI
C → Chest X-ray for pneumothorax or pneumonia
D → D-dimer if PE suspected
E → Esophageal / GI causes if cardiac ruled out
💡 Tip (Clue):
“Chest pain → Rule out 4 killers first: MI, PE, Aortic dissection, Pneumothorax.”
📘 Reference: Harrison 22/e, Ch. 243; Braunwald’s Cardiology, 12/e.
How to answer:
MONA–BASH → Reperfusion.
Model Answer:
1️⃣ Immediate:
- Morphine (pain), Oxygen, Nitroglycerin, Aspirin 325 mg chewable.
2️⃣ Reperfusion: - PCI preferred (within 90 min).
- Thrombolysis (Tenecteplase/Alteplase) if PCI unavailable < 12 h.
3️⃣ Adjuncts: - Beta-blocker (if no shock), ACE inhibitor, Statin, Heparin.
4️⃣ Long-term: - Dual antiplatelet (1 yr), statin, risk-factor control.
Tip (Clue): “Time = muscle; PCI within 90 min saves heart.”
Because NSTEMI (Non-ST Elevation Myocardial Infarction) is not caused by complete coronary occlusion, hence thrombolysis offers no benefit and may cause harm due to bleeding risk.
MX of STEMI
Management Approach in NSTEMI:
- Antiplatelets: Aspirin + Clopidogrel
- Anticoagulant: Enoxaparin or Heparin
- Anti-ischemic: Nitrates, β-blockers
- High-intensity statin
- Early invasive evaluation → Coronary angiography ± PCI if indicated
Heart attack (Myocardial infarction): Ischaemic necrosis of myocardium due to acute coronary artery occlusion — presents with chest pain, ECG changes, raised troponin.
• Cardiac arrest: Sudden cessation of cardiac mechanical activity (no pulse) — patient unresponsive, no breathing. Can be caused by VF/VT secondary to MI (so MI may lead to cardiac arrest).
• Key: MI = disease process; cardiac arrest = consequence (loss of circulation) requiring immediate CPR/defibrillation.
Tip (Clue): “Heart attack can cause cardiac arrest — but not vice versa.”
Feature | Urgency | Emergency |
BP | ≥180/120 mmHg | ≥180/120 mmHg + organ damage |
Symptoms | Headache, anxiety | Encephalopathy, papilledema, renal failure |
Management | Oral drugs (gradual ↓ over 24–48 h) | IV drugs (↓ MAP ≤25% in 1 h) |
Examples | Noncompliance | Eclampsia, aortic dissection |
Tip (Clue): “Emergency = End-organ damage.”
Confirm diagnosis → classify → treat stepwise.
Model Answer:
Diagnosis:
- Average of ≥2 readings on ≥2 visits.
- Normal: <120/80 mmHg
- Elevated: 120–129/<80
- Stage 1: 130–139 / 80–89
- Stage 2: ≥140 / ≥90
Management:
1️⃣ Lifestyle: ↓ salt (<5 g/day), exercise 150 min/week, no smoking.
2️⃣ Drugs (Step 1): ACE inhibitor / ARB / CCB / Thiazide.
3️⃣ If uncontrolled: Combination (2–3 drugs).
4️⃣ Monitor: Target BP <130/80 mmHg.
Tip (Clue): “Diagnose slow — lower slow; never crash BP.”
Definition:
Antibiotic resistance is the ability of bacteria to survive and multiply despite the presence of an antibiotic that was previously effective against them.
Mechanism (short):
🔹 Mutation in bacterial genes
🔹 Horizontal gene transfer (plasmids)
🔹 Overuse and misuse of antibiotics → selection pressure → resistant strains (e.g., MRSA, NDM-1).
Consequences:
➡️ Longer illness duration
➡️ Increased hospital stay & cost
➡️ Higher morbidity and mortality
➡️ Failure of standard treatments
Prevention Strategies (4 Key Levels):
1️⃣ Prescriber level:
- Use antibiotics only when indicated (bacterial infection, not viral).
- Follow antibiotic stewardship protocols.
- Prefer narrow-spectrum agents when possible.
- Avoid empirical use without culture/sensitivity.
2️⃣ Patient level:
- Complete full course; do not self-medicate.
- Avoid using leftover or shared antibiotics.
3️⃣ Hospital level:
- Strict infection control (hand hygiene, isolation of resistant cases).
- Antibiotic policy and periodic audits.
4️⃣ National & Global level:
- Surveillance programs (e.g., ICMR-AMRSN, WHO GLASS).
- Public awareness campaigns.
- Regulation of over-the-counter antibiotic sales.
💡 Tip (Clue):
“Use antibiotics like fire — powerful when controlled, disastrous when misused.”
📘 Reference:
Harrison 22/e, Ch. 128; WHO Global Action Plan on AMR, 2023.
Respiratory Emergencies
Differentiate on onset, reversibility, inflammation, and therapy.
Diagnosis:
• Asthma: Variable respiratory symptoms (wheeze, dyspnea), reversibility on bronchodilator testing (>12% and 200 mL FEV1 improvement), atopy history common, younger onset.
• COPD: Persistent progressive dyspnea, chronic productive cough, smoking history, non-fully reversible airflow limitation on spirometry (post-bronchodilator FEV1/FVC <0.7).
Key: Reversibility/severity & smoking history differentiate;
ICS = core for asthma,
Bronchodilators + Lifestyle (smoking cessation) core for COPD.
Feature | Asthma | COPD |
Onset | Childhood / young | > 40 yr, smoker |
Course | Episodic, variable | Progressive |
Reversibility | Complete with bronchodilator | Partial |
Inflammation | Eosinophilic | Neutrophilic |
FEV₁ Reversibility | > 12 % & > 200 mL ↑ after BD | < 12 % or < 200 mL |
Treatment | ICS + SABA (Rescue) | LABA/LAMA ± ICS, stop smoking |
Tip (Clue): “Asthma → variable reversible airflow limitation; COPD → fixed obstructive pattern.”
Assess severity: Inability to speak, RR > 30, PEF < 50 %, SpO₂ < 90 %.
Immediate steps:
1️⃣ O₂ to maintain SpO₂ > 94 %.
2️⃣ Nebulized Salbutamol + Ipratropium q20 min × 3.
3️⃣ IV Hydrocortisone 100 mg or Oral Prednisolone 40 mg.
4️⃣ If no response → IV Magnesium sulfate 2 g over 20 min.
5️⃣ Intubate if exhausted / rising CO₂.
Tip (Clue): “O₂ + SABA + Steroid = core triad for acute asthma.”
Recognize trigger → stabilize → support ventilation.
Model Answer:
- Diagnosis: ↑ Dyspnea / sputum volume / purulence.
- Management:
• O₂ (low-flow) to keep SpO₂ 88–92 %.
• Nebulized SABA + SAMA (every 20 min × 3).
• IV Hydrocortisone 100 mg 8-hourly → Oral Prednisolone 40 mg 5 days.
• Antibiotic if purulent sputum (Azithro / Amoxy-Clav).
• NIV (BiPAP) if pH < 7.35 / PaCO₂ > 45.
Tip (Clue): “Target SpO₂ ≈ 90 % — too much O₂ can worsen CO₂ retention.”
Clinical + CXR + Empiric therapy per guidelines.
Model Answer:
- Diagnosis: Fever, cough, pleuritic pain + CXR infiltrate.
- Severity: CURB-65 ≥ 2 → admit.
- Treatment:
• OPD: Amoxy-Clav + Azithromycin (5 days).
• IPD: IV Ceftriaxone + Azithromycin or Levofloxacin.
• Add O₂, fluids, antipyretic.
Tip (Clue): “Start antibiotic within 4 h of diagnosis.”
Empirical therapy means starting treatment based on the most likely cause of a disease before the exact diagnosis or organism is confirmed by investigations.
Importance = In life-threatening or rapidly progressive infections, waiting for lab results may delay life-saving therapy.
Eg ;- Nitrofurantoin in UTI
Cefixime in typhoid .
Definition (Berlin criteria) → supportive care.
Model Answer:
Definition (Berlin 2012): Acute onset (< 1 wk) bilateral opacities not due to cardiac failure + PaO₂/FiO₂ < 300.
Management:
- Low tidal volume ventilation (6 mL/kg IBW).
- PEEP optimization to maintain oxygenation.
- Prone positioning if PaO₂/FiO₂ < 150.
- Fluids: Conservative strategy.
- Treat underlying cause.
Tip (Clue): “ARDS = O₂ support + low VT + prone ventilation.”
- Need for ICU & oxygen capacity building.
- Importance of indigenous vaccine development (Covaxin/Covishield).
- Role of digital health (CoWIN, tele-consultation).
- Public awareness & infodemic control.
- Strengthening primary care and epidemic preparedness (IDSP).
Tip (Clue): “COVID → taught preparedness, digital health & self-reliance.”
Neurology & Cardiorespiratory Emergencies
Differentiate ischemic vs hemorrhagic; stress early imaging.
Model Answer:
- Diagnosis: CT brain (to rule out bleed).
- Ischemic stroke:
- IV Alteplase (tPA) 0.9 mg/kg if within 4.5 hours.
- Control BP (<185/110), antiplatelet (Aspirin 150 mg), statin.
- Hemorrhagic stroke:
- Control BP (<140), reverse anticoagulants, neurosurgical consult.
- Rehabilitation: Physiotherapy + speech therapy.
Tip (Clue): “CT first — then treat; time = brain.”
Core Concept:
Early brain imaging (preferably Non-Contrast CT scan) is the single most critical step in stroke evaluation — because treatment depends entirely on the stroke type.
🔹 Reason 1: To Differentiate Stroke Type
- Ischemic Stroke → due to arterial occlusion → Thrombolysis indicated.
- Hemorrhagic Stroke → due to vessel rupture → Thrombolysis contraindicated.
⮕ Both can look similar clinically, so imaging is mandatory before treatment.
🧠 Without CT/MRI, you can’t safely start thrombolysis.
🔹 Reason 2: Time-Sensitive Thrombolysis
- Thrombolytic therapy (e.g., Alteplase, Tenecteplase) must be given within 4.5 hours of symptom onset.
- Early imaging saves time, confirming ischemic stroke and allowing timely reperfusion.
⮕ “Time is Brain” — each minute of delay = neuronal loss.
🔹 Reason 3: To Detect Mimics or Complications
- Mimics: hypoglycemia, seizures, migraine, tumors.
- Complications: early edema, mass effect, hemorrhagic transformation.
⮕ Imaging helps avoid wrong treatment and plan surgical management if bleeding is present.
💙 Summary
Stroke symptoms → Immediate CT brain (within 20 min) →
➡️ Ischemic → Thrombolysis (if <4.5 hr) + Antiplatelets later
➡️ Hemorrhagic → Stop anticoagulants, control BP, neurosurgical opinion
💙 Tip:
“Treat stroke with your clock and your scan — not your guess.”
ABCDE → drug escalation → identify cause.
Model Answer:
- Airway, O₂, IV access, glucose (rule out hypoglycemia).
- Step 1: Lorazepam 4 mg IV (repeat after 10 min).
- Step 2: Phenytoin 20 mg/kg IV (max 50 mg/min) or Valproate.
- Step 3: If persistent → IV Midazolam / Propofol (ICU).
- Identify cause: infection, metabolic, stroke, drug withdrawal.
Tip (Clue): “Stop seizure fast — brain injury starts within 5 min.”
Early antibiotics before LP if unstable.
Model Answer:
- Suspect: Fever, neck rigidity, altered sensorium.
- Investigate: CBC, LP (↑ cells, ↓ sugar, ↑ protein).
- Empiric treatment:
- Adults: Ceftriaxone + Vancomycin ± Dexamethasone.
- >50 yr / immunocompromised: add Ampicillin (Listeria).
- Supportive: IV fluids, anticonvulsants if seizures.
Tip (Clue): “If suspect meningitis → antibiotics first, LP next.”
Diagnosis → classification → regimen.
Model Answer:
Diagnosis: CBNAAT / TrueNat + Chest X-ray + Sputum AFB.
Regimen (Drug-sensitive):
- Intensive phase: HRZE × 2 months
- Continuation: HRE × 4 months
(Weight-band based FDCs under NTEP.)
Follow-up: Sputum at 2, 4, 6 months.
Support: Nutritional support (₹1000/month under Nikshay Poshan Yojana).
Tip (Clue): “CBNAAT before ATT — never treat blindly.”
Goal
To eliminate TB from India by 2025 (5 years ahead of the global SDG target of 2030).
🔹 Vision
“TB Mukt Bharat” — Zero deaths, disease, and poverty due to TB.
🔹 Strategy — DTPB
D → Detect early → Use CBNAAT/TrueNat, chest X-ray for all suspected cases.
T → Treat effectively → All-oral short regimens (BPaLM/BPaL).
P → Prevent → TB Preventive Therapy (TPT) for household contacts; infection control.
B → Build → Digital surveillance (Nikshay), private sector linkages, community participation.
🔹 Recent Highlights (2025)
- Services expanded to Ayushman Arogya Mandirs.
- Nikshay Mitras under PM TB Mukt Bharat Abhiyan for patient support.
- Nutrition aid via Nikshay Poshan Yojana (₹1000/month).
- Record case notifications: >26 lakh (2024) — highest ever.
🔹 Challenges
- Persistent undernutrition, MDR-TB, and late diagnosis.
- Social stigma and private sector underreporting.
💙 Tip:
“Detect early, Treat completely, Prevent spread — that’s the NTEP 2025 mantra.”
Always do 15 min wash under tap water with soap.
classify category and manage as per category.
lyssa Virus type 1 most specific Q ** UPSC CMS 2024 ** CMS 2021 ****2019 & 2016 & 2002
Category | Question | Wound mx | Rabies vaccine (ARV) |
RiG IU /KG |
Cat 1 Q | Lick, touch on intact skin Q | Yes | — Q Q — | ———- |
Cat 2 2021 *** | Abrasion Q CMS 2021 Oozing /
| Yes | Yes | ———– |
Cat 3** UPSC CMS 2024 **
| Deep wound & laceration Bleeding cms & any wild animal | Yes QQ
| Yes QQ
| Yes (Equine RIG – 40 Human RIG – 20) |
Wash is initial step and very important step for all type of Category (15 -20 min with soap + water) and
So basically, RIG is only for category 3 and ARV for cat 2 & 3 Q mcq faqs
RIG is good if given within 72 hour . However can be given till 7 days and very less effective if given after 7 days . So if patient come after 7 days as category 3 then we should not give RIG. Q imp for CMS 2024 & 2025
Pre exposure prophylaxis | Day 0, 7, 21 or 28 | 1 site Im or id | 3 dose 3 visit |
|
Post exposure prophylaxis | Day 0,3,7,14,28 | 1 site Im | 5 dose 5 visit | Essen regime |
| Day 0,3,7,28 Q Q | 2 site Id | 8 DOSE 4 VISIT | Thai regime Q |
Re exposure prophylaxis | Day 0,3 | 1 site I’m or id | 2 dose 2 visit |
|
prefer Thai regimn
Rabies – Key Symptoms (Ultra-Short)
- Incubation: 1–3 months
- Early: Fever, malaise, tingling at bite site
- Neurologic:
- Furious type: Hydrophobia, aerophobia, agitation
- Paralytic type: Ascending paralysis
- Late: Coma → Respiratory failure → Death
💙 Tip: Hydrophobia = hallmark of rabies.
***Very important for UPSC CMS*** 2020 & 2016 & 2009 & 2018 &
Case | Status | Clean wound / within 6 hours | Contaminated / More than 6 hours |
Case 1 Q | Fully immunized within 5 years | Only wound mx | Only wound mx |
Case 2 | Fully immunized within 5 to 10 years | TT single dose | TT single dose |
Case 3 Q | Fully immunized more than 10 years | TT single dose | TT single dose+ TIG |
Case 4 Q | Unknown status or no Vaccination upsc cms 2016 | TT two dose | TT two dose + TIG |
Clostridium Tetani (spore is also features of this bacteria)
SPORE can be killed by Gamma Radiation Q CMS 2017
MOA- potent exotoxin – Tetanospasmin & Tetanolysin Q
Soil is Source of infection & reservoir at the same time Q **UPSC CMS 2023**
Direct inoculation is route of transmission
TIG dose: 250 IU IM (500 IU if major wound).
Tip (Clue): “TT for everyone; TIG if incomplete + dirty wound.”
- Incubation: 3–21 days (shorter = severe).
- Early: Jaw stiffness (trismus / lockjaw), neck rigidity.
- Later: Painful muscle spasms, risus sardonicus (grin), opisthotonus.
- Severe: Laryngospasm → respiratory failure → death.
💙 Tip: Trismus + history of wound = Tetanus until proved otherwise.
First aid → assess → specific therapy.
Model Answer:
- Do NOT: Cut, suck, or apply tourniquet.
- Immobilize limb at heart level.
- Identify snake type (neurotoxic, hemotoxic, myotoxic).
- Supportive: Airway, O₂, fluids.
- Antivenom (ASV):
- Indication: Local swelling, neuro signs, coagulopathy.
- Dose: 10 vials IV over 1 hr → repeat till symptoms resolve.
- Neurotoxic: Give neostigmine + atropine if indicated.
Tip (Clue): “Immobilize, transport, give ASV — nothing else.”
Must know
1️⃣ Non-Poisonous Snakes
- Rat snake, Python
🔹 2️⃣ Poisonous Snakes
(a) Elapidae → Neurotoxic → Cobra, Krait
(b) Viperidae → Vasculotoxic → Russell’s viper, Saw-scaled viper
(c) Hydrophidae → Myotoxic → Sea snakes
💙 Tip: Cobra = Neurotoxic, Viper = Hemotoxic, Sea snake = Myotoxic.
Supportive → antidotes → monitoring.
Model Answer:
Clinical triad: Miosis, salivation, fasciculations.
Treatment:
1️⃣ Decontaminate: Remove clothes, wash skin.
2️⃣ Airway + O₂.
3️⃣ Atropine: 2 mg IV q5 min till secretions dry, pupils dilate.
4️⃣ Pralidoxime: 30 mg/kg IV over 30 min → 8–10 mg/kg/hr infusion.
5️⃣ Supportive: Fluids, suction, monitor ECG.
Tip (Clue): “Atropine till lungs dry — not till heart rate normal.”
Definition → classification → management.
Model Answer:
Definition: Hb < 13 g/dL (male), < 12 g/dL (female).
Microcytic | normocytic | macrocytic |
SITLA
|
All left |
Deficiency of
|
How to differentiate Microcytic Q Q Q Q
| Sidero blastic | IDA**cms 2023** | Anemia of chronic disease | thalassemia |
s. Iron |
Opposite to IDA | ↓ | Same as IDA | N |
TIBC | ↑ | ↓ ** | N | |
Ferritin | ↓ | **↑ | N | |
Saturation | ↓ | Same as IDA | N | |
Free Erythrocyte porphyrin |
INCREASE | Normal Or Decrease | ||
Now concept
Sideroblastic is opposed to IDA —-ok.
AOCD is same as IDA except ferritin & TIBC.
Free Erythrocyte protoporphyrin increases in all except thalassemia.
Treatment:
- Iron: Ferrous sulfate 100–200 mg elemental iron/day × 3 months after correction.
- Treat cause (worm, malnutrition, menorrhagia).
- Transfuse if Hb < 7 g/dL / symptomatic.
Tip (Clue): “Always correct cause + replenish stores.”
Reference Pg no 252 (Target CMS 2025 RR)
Endocrinology
How to answer:
List all four diagnostic pathways.
Model Answer:
Diagnosis made if any one of the following is present (confirmed on repeat if asymptomatic):
Test | Cut-off |
Fasting plasma glucose (FPG) | ≥ 126 mg/dL (after ≥ 8 h fast) |
2-h OGTT (75 g) | ≥ 200 mg/dL |
HbA1c | ≥ 6.5 % |
Random glucose | ≥ 200 mg/dL + classic symptoms |
Tip (Clue): “126–200–6.5–200 → FPG, OGTT, A1c, Random.”
Lifestyle → Pharmacotherapy → Monitoring → Complications.
Model Answer:
1️⃣ Lifestyle: Diet (low GI, high fiber), exercise ≥ 150 min/week, weight loss 5–10 %.
2️⃣ Drugs:
- 1st line: Metformin (unless contraindicated).
- Add-on (based on comorbidity):
• ASCVD → SGLT2 inh. (Empagliflozin) or GLP-1 RA (Semaglutide)
• HF/CKD → SGLT2 inh.
• Obesity → GLP-1 RA.
3️⃣ Monitoring: FPG, PPG, HbA1c every 3 months.
4️⃣ Prevent complications: BP control (<130/80), statin, annual eye/foot/kidney check.
Tip (Clue): “Metformin first — then match drug to comorbidity.”
**UPS INSULIN type
**UPSC CMS 2023** 2022 & 2020 & 2019 & 2017
Ultra short | Short | Rapid
| Inter- mediate | Long | Ultra Long |
Inhalation route | S/C route | ||||
Afrezza | Lispro Aspart Gluliscine
| Regular | NPH Lente | Glargine Detemir
| Degludec ** cms 2023*
|
For post prandial hyperglycemia | For maintenance | ||||
Page no 222 Target CMS 2025 RR
Symptoms of hyperglycemia (polyuria, polydipsia, and polyphagia for the last 3 months) cms 2023 + random blood glucose ≥ 200 mg/dL is diagnostic of diabetes mellitus, without requiring further tests.
Diagnostic Triad of DKA Q CMS 2025
- Hyperglycemia
- Ketosis
- Metabolic acidosis (↓ serum bicarbonate, ↓ pH)
🩺 DKA Management – Stepwise Approach (Harrison 22nd Ed.)
1️⃣ Fluid Resuscitation
- Initial fluid: Start with 0.9% Normal Saline (NS) at 15–20 mL/kg/hr (~1–1.5 L in first hour)
- Switch to 0.45% NS if corrected serum sodium is normal or elevated
2️⃣ Potassium Replacement
- Check serum K⁺ before insulin:
- If K⁺ < 3.3 mEq/L → hold insulin, give K⁺ until >3.3
- If K⁺ 3.3–5.0 mEq/L → add 20–30 mEq K⁺ per liter of IV fluid
- If K⁺ > 5.0 mEq/L → monitor closely, no immediate replacement
3️⃣ Insulin Therapy
- Start after initial fluid resuscitation and K⁺ > 3.3
- IV regular insulin:
- Bolus: 0.1 units/kg (optional)
- Infusion: 0.1 units/kg/hr
- Goal: Reduce glucose by 50–70 mg/dL/hr
- When glucose reaches 200 mg/dL, reduce insulin rate to 0.02–0.05 units/kg/hr and add Dextrose (D5W) to fluids
4️⃣ Correction of Acidosis
- Insulin alone usually corrects acidosis
- Bicarbonate therapy:
- Reserved for pH < 6.9
- Dose: 100 mmol in 400 mL sterile water + 20 mEq K⁺ over 2 hrs
5️⃣ Phosphate Replacement
- Not routinely required
- Consider if serum phosphate < 1.0 mg/dL, cardiac dysfunction, or respiratory depression
6️⃣ Monitoring
- Hourly: Glucose, electrolytes, venous pH, anion gap
- Every 2–4 hrs: Serum ketones, bicarbonate, creatinine
- Watch for cerebral edema, especially in children
📌 End Goals of Therapy
- Closure of anion gap
- Normalization of bicarbonate and pH
- Resolution of ketonemia
Feature | DKA | HHS |
Onset | Rapid (< 24 h) | Gradual (> 48 h) |
Glucose | 250–600 mg/dL | > 600 mg/dL |
Ketones | Present | Absent/minimal |
pH | < 7.3 | > 7.3 |
HCO₃ | < 18 mmol/L | > 18 mmol/L |
Mortality | 1–5 % | Higher (10–20 %) |
Tip (Clue): “Acidotic DKA — Dehydrated HHS.”
Model Answer:
- Definition: Plasma glucose < 70 mg/dL.
- Symptoms: Sweating, tremor, palpitation, confusion.
- Treatment: If conscious → 15 g oral glucose; if unconscious → IV 25–50 mL of D50 or IM Glucagon 1 mg.
- Prevent: Regular meals, dose adjustment, patient education.
Tip (Clue): “Rule of 15 — 15 g glucose → recheck 15 min → repeat if < 70.”
Clinical: Fatigue, weight gain, constipation, cold intolerance, bradycardia, dry skin.
Investigations: ↑ TSH + ↓ Free T₄.
Management: Levothyroxine 1.6 µg/kg/day (morning empty stomach).
Adjust dose by TSH every 6 weeks.
Tip (Clue): “Primary = ↑ TSH ↓ T₄; Central = ↓ TSH ↓ T₄.”
Feature | Hypothyroid | Hyperthyroid |
Metabolism | ↓ (Weight gain) | ↑ (Weight loss) |
Pulse | Bradycardia | Tachycardia |
Skin/Hair | Dry, coarse | Warm, moist |
Reflexes | Sluggish | Brisk |
TSH/T₄ | ↑ TSH, ↓ T₄ | ↓ TSH, ↑ T₄ |
Tip (Clue): “Opposite spectrums — energy low vs high.”
Define → list types → classify by transmission and chronicity.
Model Answer:
Viral hepatitis = inflammation of liver due to hepatotropic viruses (A, B, C, D, E).
Virus | Transmission | Chronicity | Vaccine |
A | Feco-oral | Acute only | Yes |
B | Parenteral, sexual, vertical | Chronic possible | Yes |
C | Parenteral | Chronic common | No |
D | Requires HBV coinfection | Chronic | No |
E | Feco-oral | Usually acute | No (in pipeline) |
Tip (Clue): “A & E → enteral ; B C D → parenteral.”
Mcc outbreak in india = A UPSC CMS 2020**
Most chronic C Q
↑ mortality in pregnancy = E **UPSC CMS 2021**
All are RNA except hepatitis B ( DNA virus)
List key antigens / antibodies with meaning.
Model Answer:
Marker | Interpretation |
HBsAg | Current infection |
Anti-HBs | Immunity / past infection / vaccination |
HBeAg | High infectivity |
Anti-HBe | Low infectivity |
Anti-HBc IgM | Acute infection |
Anti-HBc IgG | Past / chronic infection |
Tip (Clue): “Window period = only Anti-HBc IgM positive.”
- Acute inf = HBsAg (+) & IgM Anti-HBcAg
Supportive → monitoring → when to refer.
Model Answer:
- Rest + nutrition (high-carb, low-fat diet)
- Avoid hepatotoxins – alcohol, paracetamol
- Monitor LFT, INR, bilirubin
- Treat complications:
- Encephalopathy → lactulose + rifaximin
- Coagulopathy → vit K, FFP
- Refer if: jaundice > 4 weeks, INR > 1.5, altered sensorium.
Tip (Clue): “Supportive = mainstay; only HBV/HCV may need antivirals.”
Cirrhosis = diffuse hepatic fibrosis with regenerative nodules causing portal hypertension & liver failure.
Complications: Ascites, variceal bleed, encephalopathy, HCC.
Management:
1️⃣ Etiologic – stop alcohol, treat HBV/HCV.
2️⃣ Diet – protein 1 g/kg (restrict if encephalopathy).
3️⃣ Ascites – salt restriction + spironolactone ± furosemide.
4️⃣ Varices – propranolol, endoscopic banding.
5️⃣ Encephalopathy – lactulose, rifaximin.
6️⃣ HCC screening – USG + AFP every 6 months.
Tip (Clue): “Cirrhosis = treat cause + prevent complications + consider transplant.”
Diagnosis → graded management.
Model Answer:
- Confirm: Shifting dullness, USG.
- Restrict salt < 2 g Na/day.
- Diuretics: Spironolactone 100 mg ± Furosemide 40 mg (ratio 100:40).
- Therapeutic paracentesis: Remove ≤ 5 L with albumin 6–8 g/L removed.
- Refractory: TIPS / Transplant.
Tip (Clue): “Spironolactone = drug of choice for cirrhotic ascites.”
Supportive → specific → monitor.
Model Answer:
- NPO, aggressive IV fluids (Ringer’s lactate).
- Analgesia: Tramadol / Fentanyl.
- O₂ / monitor urine output.
- If severe (BISAP ≥ 3): ICU care.
- No routine antibiotics unless infected necrosis.
- ET feeding within 48 h preferred.
- Treat cause: gallstones → cholecystectomy; alcohol → abstain.
Tip (Clue): “Early fluid + nutrition = survival.”
Resuscitate → identify → definitive treatment.
Model Answer:
- Airway, 2 IV lines, fluids, cross-match.
- Investigate: Hb, LFT, INR, Urea, Endoscopy.
- Specific:
- Peptic ulcer: PPI infusion + endoscopic therapy.
- Variceal bleed: Octreotide infusion + band ligation + antibiotics + TIPS if refractory.
- Transfuse PRBC if Hb < 7 g/dL.
Tip (Clue): “2 IV lines, O₂, NG tube, PPI before endoscopy.”
State triple therapy + adjuncts.
Model Answer:
- General: Stop NSAIDs, avoid smoking/alcohol.
- Drugs:
- H. pylori triple therapy (14 days):
PPI + Clarithromycin + Amoxicillin (or Metronidazole). - Maintenance: PPI 4–6 weeks.
- H. pylori triple therapy (14 days):
- Complications: bleed, perforation, gastric outlet obstruction → surgical referral.
Tip (Clue): “Treat H. pylori = cure PUD.”
How to answer:
Mention diagnosis → drainage → cause-specific therapy.
Model Answer:
- Diagnosis: Chest X-ray (blunting of costophrenic angle) → USG → Pleural tapping for analysis (protein, LDH, cell count, ADA).
- Classification: Transudate vs Exudate (Light’s criteria).
- Treatment:
- Transudate: Treat underlying cause (HF, nephrotic syndrome).
- Exudate: Antibiotics for empyema, ATT for TB, malignant drainage if needed.
Tip (Clue): Don’t remove > 1.5 L fluid at once → re-expansion edema risk.
Pleural effusion-Light’s criteria
** UPSC CMS 2024 ** **cms 2022** & 2018 & 2021 & 2016 & 2004 & 2006
Transudate Transparent | Exudate** UPSC CMS 2024 ** Not transparent due to more protein, more LDH & LOW Glucose **cms 2022** |
< 0.5 Q | > 0.5** cms **2024 |
< 0.6 Q | > 0.6** cms **2024 |
Fluid LDH < 2/3 of upper limit of Serum | Fluid LDH > 2/3 of upper limit of Serum** UPSC CMS 2024 ** |
All Vital Organ & Badi Badi Bimari (Heart) CHF Q (Liver) CLD Q – cirrhosis (portal HTN)/ SVC obstruvtion (kidney) CKD/ Q nephrotic + myxodema Q | Neoplasm Q **UPSC CMS 2023**+ Infection Q + Inflammatory disease Q (Rheumatoid) |
One liner mCQs
Pleural effusion with LOW GLUCOSE seen in RA **UPSC CMS 2009**
SAAG > 1.1 = Transudate ascites e.g. PORTAL HTN **UPSC CMS 2019** & 2014 & 2009
SAAG < 1.1 = Exudate ascites ** UPSC CMS 2024 **
How to answer:
Confirm diagnosis → classify → treat stepwise.
Model Answer:
Diagnosis:
- Average of ≥2 readings on ≥2 visits.
- Normal: <120/80 mmHg
- Elevated: 120–129/<80
- Stage 1: 130–139 / 80–89
- Stage 2: ≥140 / ≥90
Management:
1️⃣ Lifestyle: ↓ salt (<5 g/day), exercise 150 min/week, no smoking.
2️⃣ Drugs (Step 1): ACE inhibitor / ARB / CCB / Thiazide.
3️⃣ If uncontrolled: Combination (2–3 drugs).
4️⃣ Monitor: Target BP <130/80 mmHg.
Tip (Clue): “Diagnose slow — lower slow; never crash BP.”
Feature | Urgency | Emergency |
BP | ≥180/120 mmHg | ≥180/120 mmHg + organ damage |
Symptoms | Headache, anxiety | Encephalopathy, papilledema, renal failure |
Management | Oral drugs (gradual ↓ over 24–48 h) | IV drugs (↓ MAP ≤25% in 1 h) |
Examples | Noncompliance | Eclampsia, aortic dissection |
Tip (Clue): “Emergency = End-organ damage.”
Why examiner asks:
Checks ability to recall reversible causes.
How to answer:
Group under renal, endocrine, vascular and drug causes.
Model Answer:
- Renal: CKD, renal artery stenosis, glomerulonephritis
- Endocrine: Primary aldosteronism, Cushing’s syndrome, Pheochromocytoma, Thyroid disorders
- Vascular: Coarctation of aorta
- Drugs: OCPs, NSAIDs, Steroids, Cyclosporine
- Sleep disorders: Obstructive sleep apnea
Tip (Clue): Remember “ABCD” – Aldosteronism, Bruits (Renal), Cushing’s/Catecholamines, Drugs.
Quote DASH diet + weight loss + exercise.
Model Answer:
- Weight reduction: 5–10 % loss → ↓ SBP 5–20 mm Hg
- Dietary DASH pattern: Fruits, vegetables, low-fat dairy, ↓ salt < 5 g/day
- Exercise: ≥ 30 min brisk walk 5 days/week
- Avoid: Alcohol, smoking, high-sodium processed food
- Stress control: Yoga/meditation
Tip (Clue): Each 10 kg weight loss ≈ 5–10 mm Hg BP drop.
How to answer:
Mention five major groups + example + first-line principle.
Model Answer:
- Thiazide diuretics – Hydrochlorothiazide, Chlorthalidone
- ACE inhibitors – Enalapril, Ramipril
- ARBs – Losartan, Telmisartan
- Calcium channel blockers – Amlodipine, Diltiazem
- Beta blockers – Atenolol, Metoprolol (for specific indications)
Combination therapy if BP > 160/100 mm Hg or uncontrolled after one agent.
Tip (Clue): First-line = ACE/ARB + CCB ± Thiazide.
How to answer:
List 3–4 important effects and specific contraindications.
Model Answer:
- Side effects: Bradycardia, fatigue, cold extremities, bronchospasm, hypoglycemia masking.
- Contraindications: Asthma/COPD, bradyarrhythmia, heart block, acute HF, variant angina.
Tip (Clue): Avoid non-selective β-blockers in bronchial asthma.
How to answer:
Divide by site (atrial, junctional, ventricular) and rate.
Model Answer:
- Bradyarrhythmias: Sinus bradycardia, AV blocks.
- Tachyarrhythmias:
• Supraventricular: AF, Atrial flutter, PSVT
• Ventricular: VT, VF, Torsades de pointes.
Tip (Clue): Think “Rate ↑ or ↓ + Origin A/V.”
How to answer:
Classify as cardiac and systemic.
Model Answer:
- Cardiac: Hypertension, Rheumatic MS, IHD, Cardiomyopathy, Post-CABG.
- Systemic: Thyrotoxicosis, Alcohol intake, PE, Sepsis, Electrolyte imbalance.
Tip (Clue): “HTN + MS = most common duo for AF in India.”
How to answer:
Mention structural, electrical, toxic, and hereditary causes → investigate → prevent recurrence.
Model Answer:
- Causes: HOCM, Long QT syndrome, Brugada syndrome, Myocarditis, Drugs (cocaine, amphetamines).
- Evaluation: Family history, ECG, Echocardiography, Cardiac MRI, Genetic testing.
- Prevention: Beta-blockers, ICD implantation in high-risk.
Tip (Clue): In young = think channelopathies > atherosclerosis.